8,12-Dimethyl-3-(4-trifluoromethyl-phenyl)-4,9,10,11-tetraoxa-tricyclo[6.2.2.0*1,6*]dodec-6-en-5-one

ID: ALA2435060

PubChem CID: 73346346

Max Phase: Preclinical

Molecular Formula: C17H15F3O5

Molecular Weight: 356.30

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1O[C@]23CC(c4ccc(C(F)(F)F)cc4)OC(=O)C2=C[C@@]1(C)OO3

Standard InChI:  InChI=1S/C17H15F3O5/c1-9-15(2)7-12-14(21)22-13(8-16(12,23-9)25-24-15)10-3-5-11(6-4-10)17(18,19)20/h3-7,9,13H,8H2,1-2H3/t9?,13?,15-,16+/m1/s1

Standard InChI Key:  ZHHRIFKTPFTONY-KWQPOOPASA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    4.3697  -11.9905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1072  -11.5656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1072  -10.7117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3697  -10.2785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1433  -10.9684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7259  -11.2292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8476  -11.9942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7361  -10.1844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6322  -11.5656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6333  -10.7123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8988  -10.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1587  -10.7103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1576  -11.5637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8966  -11.9937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9011   -9.4662    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4451  -11.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7349  -11.5624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0237  -11.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0213  -12.7921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7362  -13.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4444  -12.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6947  -13.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4003  -12.7907    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6939  -14.0225    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4052  -13.6046    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 10  4  2  0
  9  1  1  6
  1  2  1  0
  2  3  1  0
  3  4  1  0
  9  5  1  0
  5  6  1  0
  3  6  1  0
  2  7  1  0
  3  8  1  1
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 11 15  2  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 13 16  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
M  END

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BALB/3T3 (534 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 356.30Molecular Weight (Monoisotopic): 356.0872AlogP: 3.46#Rotatable Bonds: 1
Polar Surface Area: 53.99Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.34CX LogD: 4.34
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.57Np Likeness Score: 1.13

References

1. Hossain MI, Świtalska M, Peng W, Takashima M, Wang N, Kaiser M, Wietrzyk J, Dan S, Yamori T, Inokuchi T..  (2013)  Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.,  69  [PMID:24056020] [10.1016/j.ejmech.2013.08.008]

Source